How much does Breyanzi (lisocabtagene maraleucel) cost in the US?
Breyanzi pricing isn’t a single fixed number because the “cost” depends on how it’s billed (list price vs. net price after discounts), treatment setting, and payer contracting. The product is a CAR-T therapy, and the total amount paid can also reflect related services (hospital administration, inpatient/outpatient care, and supportive treatments).
What affects the out-of-pocket cost for patients in the US?
Patient out-of-pocket cost usually depends on:
- Insurance type (commercial, Medicare, Medicaid)
- Whether the payer covers CAR-T for the patient’s indication
- Deductibles, coinsurance, and copays
- Prior authorization and whether any cost-sharing caps apply
Many patients ask about financial assistance because CAR-T therapies can create very high upfront bills even when coverage is approved.
Why you may see different “Breyanzi price” figures online
You’ll often find different numbers because sources may report:
- Manufacturer list price (before rebates/discounts)
- Estimates from billing data
- Net price (after negotiated discounts)
- Costs for different timeframes or components of care
If you’re trying to budget: what to ask the insurer or hospital
To get the most accurate USD figure for your case, ask the treating hospital or payer:
- The expected billed charge and estimated patient responsibility
- Whether the plan covers Breyanzi for the specific diagnosis and line of therapy
- Whether the plan requires step therapy or specific documentation
- The billing code breakdown for the drug and administration
Can I get a more exact USD number if you tell me a few details?
If you share your situation (country, insurance type, and whether you mean list price or expected patient cost), I can narrow what “Breyanzi price/cost USD” likely means and what number to look for.